Dangerous and expensive screening and treatment for rare childhood diseases: The case of krabbe disease
- 1 January 2011
- journal article
- review article
- Published by Wiley in Developmental Disabilities Research Reviews
- Vol. 17 (1) , 15-18
Abstract
Public policy surrounding newborn screening is in flux. New technology allows more screening for more diseases at lower cost. Traditional criteria for target diseases have been criticized by leading health policymakers. The example of newborn screening for Krabbe disease highlights many of the dilemmas associated with population‐based screening programs. Krabbe is difficult to diagnose, variable in its natural history, and does not always respond to treatment. The only available treatment is hematopoietic stem cell transplantation, which is expensive, risky, and of uncertain efficacy. This article analyzes the debate about Krabbe as an example of the sorts of debates that will likely arise for many more diseases over the next decade. I conclude that pilot programs in pioneer states should be carefully evaluated before testing for Krabbe is universalized. © 2012 Wiley Periodicals, Inc. Dev Disabil Res Rev 2011; 17:15–18.Keywords
This publication has 15 references indexed in Scilit:
- Newborn screening for lysosomal storage disordersAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Inborn errors of metabolism in Latin America: challenges and opportunitiesJournal of Inherited Metabolic Disease, 2010
- Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and EthicsPublic Health Genomics, 2009
- Newborn Screening for Krabbe Disease: the New York State ModelPediatric Neurology, 2009
- Newborn Screening for Krabbe Disease — A Grand Experiment Changes Lives, But Cries for OversightNeurology Today, 2008
- Cost-Effectiveness of Neonatal Screening for Medium Chain acyl-CoA Dehydrogenase Deficiency: The Homogeneous Population of the NetherlandsThe Journal of Pediatrics, 2007
- Newborn screening in North AmericaJournal of Inherited Metabolic Disease, 2007
- Newborn Screening Technology: Proceed With CautionPediatrics, 2006
- Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's DiseaseNew England Journal of Medicine, 2005
- Screening of Infants and Mortality Due to NeuroblastomaNew England Journal of Medicine, 2002